IRIDEX (NASDAQ:IRIX – Get Free Report) and Microvision (NASDAQ:MVIS – Get Free Report) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends.
Institutional and Insider Ownership
20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 30.9% of Microvision shares are owned by institutional investors. 7.4% of IRIDEX shares are owned by company insiders. Comparatively, 1.0% of Microvision shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Volatility & Risk
IRIDEX has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, Microvision has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500.
Profitability
Net Margins | Return on Equity | Return on Assets | |
IRIDEX | -14.61% | -290.57% | -22.86% |
Microvision | -2,295.70% | -161.24% | -92.54% |
Earnings & Valuation
This table compares IRIDEX and Microvision”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
IRIDEX | $48.80 million | 0.32 | -$8.91 million | ($0.43) | -2.13 |
Microvision | $4.70 million | 59.93 | -$96.92 million | ($0.44) | -2.57 |
IRIDEX has higher revenue and earnings than Microvision. Microvision is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations for IRIDEX and Microvision, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
IRIDEX | 0 | 0 | 0 | 0 | 0.00 |
Microvision | 0 | 1 | 2 | 0 | 2.67 |
Microvision has a consensus price target of $2.50, indicating a potential upside of 121.24%. Given Microvision’s stronger consensus rating and higher possible upside, analysts plainly believe Microvision is more favorable than IRIDEX.
About IRIDEX
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
About Microvision
MicroVision, Inc. develops and sells lidar sensors and software used in automotive safety and autonomous driving applications. It offers a suite of light detection and ranging (lidar) sensors and perception; and validation software for automotive OEMs, advanced driver-assistance systems, and autonomous vehicle applications, as well as non-automotive applications including industrial, robotics, and smart infrastructure. The company also provides MAVIN DR, a dynamic view lidar system, which combines short, medium, and long range sense and field of view into one form; lidar sensors under the MOVIA brand name; and MOSAIK, a software that automates manual data classification or annotation process. In addition, it provides engineering services for its hardware and software products. The company markets its products to customers directly, through trade shows, and its website. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.
Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.